Antiarrhythmic drugs for atrial fibrillation: Do we need better use, better drugs or a randomized trial of ablation as primary therapy?
Nattel
Stanley
S
Research Center, Montreal Heart Institute, QC. Stanley.nattel@icm-mhi.org <Stanley.nattel@icm-mhi.org>
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000601:surgery; D017115:Catheter Ablation; D006801:Humans; D016032:Randomized Controlled Trials as Topic
D000889:Anti-Arrhythmia Agents